NORTH CHICAGO, Illinois, November 18, 2016 /PRNewswire/ --
AbbVie Inc. has filed From 424B5, form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3, with the AMF. The full document can be viewed at http://www.abbvieinvestor.com/phoenix.zhtml?c=251551&p=irol-sec#14674069
This is a disclosure announcement from PR Newswire.
SOURCE AbbVie, Inc.